Theseus Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
BPMC
Blueprint Medicines Corporation |
$102.54 | $6.47 B | -21.48 | 638 | $249.38 M |
CGEM
Cullinan Oncology, Inc. |
$10.01 | $1.29 B | -7.16 | 85 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$11.15 | $1.12 B | -5.11 | 174 | $0 |
DSGN
Design Therapeutics, Inc. |
$4.02 | $217.51 M | -3.7 | 54 | $0 |
ELVN
Enliven Therapeutics, Inc. |
$20.47 | $984.95 M | -11.97 | 46 | $0 |
ERAS
Erasca, Inc. |
$1.92 | $647.94 M | -2.83 | 126 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
GRTX
Galera Therapeutics, Inc. |
$0.05 | $5.93 M | -0.12 | 7 | $0 |
HOOK
HOOKIPA Pharma Inc. |
$1.86 | $79.07 M | -1.71 | 151 | $20.13 M |
IMRX
Immuneering Corporation |
$1.96 | $40.63 M | -0.74 | 66 | $0 |
IPSC
Century Therapeutics, Inc. |
$0.92 | $244.54 M | -1.32 | 152 | $2.24 M |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
MRSN
Mersana Therapeutics, Inc. |
$0.63 | $261.85 M | -1.91 | 123 | $36.86 M |
PMVP
PMV Pharmaceuticals, Inc. |
$1.35 | $85.40 M | -1.26 | 63 | $0 |
RCUS
Arcus Biosciences, Inc. |
$13.81 | $1.41 B | -4.98 | 577 | $117.00 M |
RLAY
Relay Therapeutics, Inc. |
$4.35 | $1.05 B | -3 | 294 | $25.55 M |
TERN
Terns Pharmaceuticals, Inc. |
$4.57 | $462.44 M | -5.67 | 66 | $0 |
XFOR
X4 Pharmaceuticals, Inc. |
$0.46 | $169.62 M | -1.51 | 127 | $0 |